 |
 |
 |
 |
|
|||||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
News
November, 2011
APIM
Therapeutics secures follow up seed funding from Birk Venture, Ro
Invest and Sarsia Seed with the support of Ventac Partners.
October, 2011
Ventac Partners completes a strategic business and market analysis
for HUNT Biosciences, the commercial arm of the largest population based biobank in Norway.
April, 2011
Mikael Oerum appointed Chairman of the Board of
HUNT Biosciences AS. HUNT
Biosciences is owned by the Norwegian Institute of Science and technology,
the Health Region Mid-Norway and the Trøndelag County of Norway.
April, 2011
Aarti Kapoor joins Boston Office to head up Strategic Market and
Product Anaalysis, see Our Team
March, 2011
APIM
Therapeutics secures a second follow up financing round from Sarsia
Seed.
September, 2010
Martin Austin and Bengt Westrin join Ventac Partners, see Our Team
June, 2010
Mikael Oerum is appointed as Chairman of Neuroscience Technologies L.S.P and Neuroscience Technology Limited, a Spanish and UK based biomedical
company with expertise in human pain neurophysiology contract research organization,
see www.nsc-tec.com.
May, 2010
The Norwegian University of Science and Technology (NTNU) secures seed funding for APIM Therapeutics with the support of Ventac Partners.
January, 2010
Spencer Ma Joins Ventac Partners, see Our Team
November, 2009
Ventac Partners, in collaboration with Amsterdam's Academic Medical Center (AMC), incorporates Regenesance, a therapeutic company focusing on nerve regeneration.
November, 2009
Madeline Yap Joins Ventac Partners, see Our Team
June, 2009
Peter Damsbo joins Ventac Partners, see Our Team
March, 2009
The Norwegian University of Science and Technology (NTNU) incorporates APIM Therapeutics with the support of Ventac Partners.
February, 2009
Ventac Partners completes a second life science project for Hong
Kong Science and Technology Parks Corporation with the purpose to evaluate
96 biomedical projects from universities and research institutes in Hong
Kong and the Guangdong Province of Mainland China to identify top candidates
for international venture capital,
see Projects
January, 2008
Mirko Stange joins Ventac Partners, see Our Team
August, 2007
Founding Partner Wolfgang Pieken leaves Ventac Partners in order to take up a position as partner of Inveni Capital, see www.invenicapital.com.
June, 2007
Ventac Partners participates in forming Inveni Life Science Fund I. Wolfgang Pieken becomes partner in Inveni Capital, and Christina Wagner joins the advisory board of Inveni Capital. See press release
May, 2007
Robert L. Buchanan joins Ventac Partners, see Our Team .
August, 2006
Lars Hedbys and Ravi Vinayak join Ventac Partners, see Our Team .
March, 2006
Mikael Ørum is appointed to the Council of Technical University of Denmark, see www.dtu.dk .
December, 2005
Mikael Ørum joins the Advisory Board of the Institute for Micro- and Nanotechnology, see www.mic.dtu.dk
January , 2005
Dr. Christina Wagner joins Ventac Partners . See Our Team
January , 2004
Ventac Partners finishs study commissioned by Hong Kong Science & Technology Parks.
October, 2003
Mikael Ørum joins FluimediX as Chairman, see www.fluimedix.com .